rs2645339

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000843.4(GRM6):​c.1227C>T​(p.Tyr409Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 1,613,020 control chromosomes in the GnomAD database, including 237,047 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19491 hom., cov: 33)
Exomes 𝑓: 0.54 ( 217556 hom. )

Consequence

GRM6
NM_000843.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: -0.947

Publications

22 publications found
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
ZNF454 (HGNC:21200): (zinc finger protein 454) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 5-178989062-G-A is Benign according to our data. Variant chr5-178989062-G-A is described in ClinVar as Benign. ClinVar VariationId is 99626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.947 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM6NM_000843.4 linkc.1227C>T p.Tyr409Tyr synonymous_variant Exon 7 of 11 ENST00000517717.3 NP_000834.2
ZNF454XR_007058600.1 linkn.5644-685G>A intron_variant Intron 5 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM6ENST00000517717.3 linkc.1227C>T p.Tyr409Tyr synonymous_variant Exon 7 of 11 5 NM_000843.4 ENSP00000430767.1

Frequencies

GnomAD3 genomes
AF:
0.500
AC:
75981
AN:
151878
Hom.:
19464
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.399
Gnomad AMI
AF:
0.311
Gnomad AMR
AF:
0.527
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.565
Gnomad SAS
AF:
0.469
Gnomad FIN
AF:
0.560
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.548
Gnomad OTH
AF:
0.472
GnomAD2 exomes
AF:
0.528
AC:
131968
AN:
249712
AF XY:
0.523
show subpopulations
Gnomad AFR exome
AF:
0.398
Gnomad AMR exome
AF:
0.571
Gnomad ASJ exome
AF:
0.475
Gnomad EAS exome
AF:
0.581
Gnomad FIN exome
AF:
0.560
Gnomad NFE exome
AF:
0.545
Gnomad OTH exome
AF:
0.526
GnomAD4 exome
AF:
0.544
AC:
794400
AN:
1461024
Hom.:
217556
Cov.:
49
AF XY:
0.539
AC XY:
391933
AN XY:
726812
show subpopulations
African (AFR)
AF:
0.392
AC:
13129
AN:
33460
American (AMR)
AF:
0.568
AC:
25375
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.474
AC:
12385
AN:
26128
East Asian (EAS)
AF:
0.551
AC:
21856
AN:
39672
South Asian (SAS)
AF:
0.452
AC:
38959
AN:
86214
European-Finnish (FIN)
AF:
0.562
AC:
29986
AN:
53362
Middle Eastern (MID)
AF:
0.423
AC:
2440
AN:
5764
European-Non Finnish (NFE)
AF:
0.556
AC:
618246
AN:
1111402
Other (OTH)
AF:
0.531
AC:
32024
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
22782
45564
68347
91129
113911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17398
34796
52194
69592
86990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.500
AC:
76047
AN:
151996
Hom.:
19491
Cov.:
33
AF XY:
0.502
AC XY:
37288
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.399
AC:
16541
AN:
41444
American (AMR)
AF:
0.528
AC:
8076
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
1651
AN:
3464
East Asian (EAS)
AF:
0.564
AC:
2887
AN:
5120
South Asian (SAS)
AF:
0.471
AC:
2272
AN:
4826
European-Finnish (FIN)
AF:
0.560
AC:
5931
AN:
10584
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.548
AC:
37266
AN:
67956
Other (OTH)
AF:
0.478
AC:
1008
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1936
3873
5809
7746
9682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
10700
Bravo
AF:
0.496
Asia WGS
AF:
0.551
AC:
1915
AN:
3478
EpiCase
AF:
0.525
EpiControl
AF:
0.518

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital stationary night blindness 1B Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
3.5
DANN
Benign
0.89
PhyloP100
-0.95
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2645339; hg19: chr5-178416063; COSMIC: COSV51442180; COSMIC: COSV51442180; API